Trial site
The Third Hospital of Nanchang
- 9running trials
- 6closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Gastric and oesophageal cancer2 trials
- Type 2 diabetes2 trials
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Obesity1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company6 trials
- Hoffmann-La Roche2 trials
- BeiGene1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- DualityBio Inc.1 trial
- and 4 more
Running trials
Recruiting
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
Active, not recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026